关注
Jörn Stitz
Jörn Stitz
Professor of Pharmaceutical Biotechnology, TH Köln
在 th-koeln.de 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1
J Stitz, CJ Buchholz, M Engelstädter, W Uckert, U Bloemer, I Schmitt, ...
Virology 273 (1), 16-20, 2000
1902000
Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells
BS Schnierle, J Stitz, V Bosch, F Nocken, H Merget-Millitzer, ...
Proceedings of the National Academy of Sciences 94 (16), 8640-8645, 1997
1711997
Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library
M Engelstadter, M Bobkova, M Baier, J Stitz, N Holtkamp, THT Chu, ...
Human gene therapy 11 (2), 293-303, 2000
712000
Identification of R-peptides in envelope proteins of C-type retroviruses
M Bobkova, J Stitz, M Engelstädter, K Cichutek, CJ Buchholz
Journal of General Virology 83 (9), 2241-2246, 2002
632002
Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine.
Y van Heuvel, S Schatz, JF Rosengarten, J Stitz
Toxins 2022, 14, 138, 2022
452022
A novel lentivirus vector derived from apathogenic simian immunodeficiency virus
J Stitz, MD Mühlebach, U Blömer, M Scherr, M Selbert, P Wehner, S Steidl, ...
Virology 291 (2), 191-197, 2001
422001
Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles
CA Merten, J Stitz, G Braun, EM Poeschla, K Cichutek, CJ Buchholz
Journal of virology 79 (2), 834-840, 2005
402005
Retroviral cell targeting vectors.
CJ Buchholz, J Stitz, K Cichutek
Current Opinion in Molecular Therapeutics 1 (5), 613-621, 1999
391999
Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins
M Engelstädter, CJ Buchholz, M Bobkova, S Steidl, H Merget-Millitzer, ...
Gene therapy 8 (15), 1202-1206, 2001
342001
Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes
MD Mühlebach, I Schmitt, S Steidl, J Stitz, M Schweizer, T Blankenstein, ...
Journal of molecular medicine 81, 801-810, 2003
272003
Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereof
JPM Langedijk, D Van Manen, J Vellinga, F Wegmann, BCS Callendret, ...
US Patent 10,369,214, 2019
232019
MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients
J Stitz, S Steidl, H Merget-Millitzer, R König, P Müller, F Nocken, ...
Virology 267 (2), 229-236, 2000
232000
Coreceptor Switch of [MLV (SIVagm)] pseudotype vectors by V3-loop exchange
S Steidl, J Stitz, I Schmitt, R König, E Flory, M Schweizer, K Cichutek
Virology 300 (2), 205-216, 2002
222002
Process design and optimization towards digital twins for HIV-gag VLP production in HEK293 cells, including purification
H Helgers, A Hengelbrock, A Schmidt, J Rosengarten, J Stitz, J Strube
Processes 10 (2), 419, 2022
212022
Digital twin for HIV-gag VLP production in HEK293 cells
A Hengelbrock, H Helgers, A Schmidt, FL Vetter, A Juckers, ...
Processes 10 (5), 866, 2022
202022
Screening of retroviral cDNA libraries for factors involved in protein phosphorylation in signaling cascades
J Stitz, PO Krutzik, GP Nolan
Nucleic acids research 33 (4), e39-e39, 2005
192005
Transposon vector-mediated stable gene transfer for the accelerated establishment of recombinant mammalian cell pools allowing for high-yield production of biologics
N Tschorn, K Berg, J Stitz
Biotechnology Letters 42, 1103-1112, 2020
182020
Components of a HIV-1 vaccine mediate virus-like particle (VLP)-formation and display of envelope proteins exposing broadly neutralizing epitopes
JF Rosengarten, S Schatz, T Wolf, S Barbe, J Stitz
Virology 568, 41-48, 2022
172022
Displaying tetra‐membrane spanning Claudins on enveloped virus‐like particles for cancer immunotherapy
IC Schneider, J Hartmann, G Braun, J Stitz, T Klamp, M Bihi, U Sahin, ...
Biotechnology Journal 13 (3), 1700345, 2018
162018
Rapid establishment of stable retroviral packaging cells and recombinant susceptible target cell lines employing novel transposon vectors derived from Sleeping Beauty
K Berg, VN Schäfer, N Bartnicki, R Eggenschwiler, T Cantz, J Stitz
Virology 531, 40-47, 2019
152019
系统目前无法执行此操作,请稍后再试。
文章 1–20